CANVAS Network

The Canadian National Vaccine Safety (CANVAS) Network is a national platform that monitors vaccine safety after vaccines are approved for use

These studies complement Canada's passive vaccine safety surveillance system by providing rapid information in early stages of each vaccine campaign

canvas-network-homepage3-small

Active Studies

COVID-19/FLU

The purpose of this study is to find out how often health problems occur after a COVID-19 and/or Influenza vaccine

Study Results

COVID-19/FLU

The purpose of this study is to find out how often health problems occur after a COVID-19 and/or Influenza vaccine (2023-present)

COVID-19

Vaccine safety monitoring for health problems after the initial doses of the COVID-19 pandemic vaccine (2021-2022)

INFLUENZA

Vaccine safety after pandemic vaccine campaigns such as H1N1 Influenza vaccine (2009) and seasonal Influenza vaccines (2009-2019 and 2022-present)

MENB

MenB safety surveillance studies conducted following immunization with Meningococcal Serogroup B vaccine

MPox

MPox safety surveillance studies examined the safety of Imvamune (MPox) vaccine

RSV

Study on how often health problems occur after respiratory syncytial virus (RSV) vaccine in pregnancy, infants, young children, and the elderly

Participant Institutions and Partners

Scroll to Top